Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.


Autoria(s): Green, Brian
Data(s)

01/05/2005

Identificador

http://pure.qub.ac.uk/portal/en/publications/chronic-treatment-with-exendin939amide-indicates-a-minor-role-for-endogenous-glucagonlike-peptide1-in-metabolic-abnormalities-of-obesityrelated-diabetes-in-obob-mice(5e3b545a-a2d0-47e8-8e5b-86c64c069f21).html

http://dx.doi.org/10.1677/joe.1.05876

http://www.scopus.com/inward/record.url?scp=18844412634&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Green , B 2005 , ' Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice. ' The Journal of endocrinology , vol 185(2) , no. 2 , pp. 307-317 . DOI: 10.1677/joe.1.05876

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1310 #Endocrinology
Tipo

article